4.5 Article

Epigenetic Changes in Individuals with Arsenicosis

Journal

CHEMICAL RESEARCH IN TOXICOLOGY
Volume 24, Issue 2, Pages 165-167

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/tx1004419

Keywords

-

Funding

  1. National Institute of Environmental Health Sciences [P30ES010126, T32 ES7018]
  2. US EPA STAR [832735]
  3. Pfizer

Ask authors/readers for more resources

Inorganic arsenic (iAs) is an environmental toxicant currently poisoning millions of people worldwide, and chronically exposed individuals are susceptible to arsenicosis or arsenic poisoning. Using a state-of-the-art technique to map the methylomes of our study subjects, we identified a large interactome of hypermethylated genes that are enriched for their involvement in arsenic-associated diseases, such as cancer, heart disease, and diabetes. Notably, we have uncovered an arsenic-induced tumor suppressorome, a complex of 17 tumor suppressors known to be silenced in human cancers. This finding represents a pivotal clue in unraveling a possible epigenetic mode of arsenic-induced disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available